Navigation Links
Results of Phase II Study of Boehringer Ingelheim's Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
Date:5/21/2012

SAN FRANCISCO, May 21, 2012 /PRNewswire/ -- Data from a Phase II trial of olodaterol presented today at the 2012 Annual International Conference of the American Thoracic Society (ATS 2012) compared the efficacy of once-daily (QD) versus twice-daily (BID) olodaterol, a long-acting beta2-agonist (LABA) that Boehringer Ingelheim is evaluating as a possible maintenance treatment for chronic obstructive pulmonary disease (COPD), delivered via the Respimat® Inhaler. In this Phase II randomized, double-blind, cross-over study, olodaterol administered QD as 5 micrograms or 10 micrograms provided a significant and identical increase in the lung function parameter FEV1 over a 24-hour period. This data completes the olodaterol monotherapy Phase II clinical trial program in patients with COPD.

"In this Phase II study, olodaterol administered once daily provided significant bronchodilation over a complete 24-hour period," said Professor Guy Joos, Head of the Department of Respiratory Diseases at Ghent University Hospital, Belgium, and the coordinating investigator for the trial. "These data are encouraging, and set the stage for olodaterol to be further investigated in Phase III studies in patients with COPD."

Results of the study found olodaterol 5 microgram QD provided significant improvement in lung function as measured by FEV1 AUC(0-12) versus twice-daily olodaterol 2 microgram, while twice-daily dosing of olodaterol 5 microgram had a better FEV1 AUC(0-12) profile versus once-daily olodaterol 10 microgram.  There were no safety or tolerability concerns seen in the study, with no relationship between total daily dose to the overall incidence of adverse events. These results were comparable to previous Phase II studies.

"These trial results and the completion of the olodaterol monotherapy Phase II clinical trial program underscore the Company's focus on advancing respiratory research and treatment,"
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Study Results of Novocures NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer
2. InspireMD Announces Positive 3-Year Results from Extended MAGICAL trial
3. ShangPharma Announces First Quarter 2012 Results
4. Inrad Optics, Inc. Announces Financial Results For First Quarter 2012
5. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
6. Patient Safety Technologies Reports First Quarter 2012 Results
7. Nephros Reports First Quarter 2012 Financial Results
8. MedClean Technologies Announces 2011 Results
9. Nile Therapeutics Reports 2012 First Quarter Financial Results
10. OphthaliX Reports First Quarter 2012 Financial Results
11. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... LOUISVILLE, Ky. , Jan. 15, 2014  Manufacturers, ... technologies must be able to protect their most ... (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because ... Industry, it steadfastly remains one of the most ...
(Date:1/15/2014)... , Jan. 15, 2014 MultiCell Technologies, Inc. (OTC ... U.S. provisional patent application concerning composition of matter, biological ... targeted tumor cell death.  This patent ... double stranded RNA molecules (VSRNAs) which interfere with the ...
(Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), the ... the United States and European ... expand moderately through 2022, with embolization particles representing ... interest in drug-eluting beads (DEBs) and radioembolization spheres ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
(Date:4/17/2014)... signs of chronic inflammation in non-cancerous prostate tissue may ... cancer than those with no inflammation, according to results ... Johns Hopkins Kimmel Cancer Center. , The link between ... with so-called high-grade prostate cancer those with a ... presence of the most aggressive and rapidly growing prostate ...
(Date:4/17/2014)... One of the most popular vaccine brands for children ... may be overlooking some cost factors when choosing vaccines, ... expensive option, according to a new study by University ... administer can be driven by numerous factors," says Sheldon ... professor of computer science and of mathematics at the ...
(Date:4/17/2014)... San Diego School of Medicine report that older women, ... major loss are more likely to be compassionate toward ... published in this month,s issue of the International ... are associated with better health and well-being as we ... improve the outcomes of individuals whose deficits in compassion ...
(Date:4/17/2014)... Hospital Pediatrician-in-Chief Jon McCullers, MD, was recently invited ... of Nature Reviews Microbiology , one of ... a world-renowned infectious disease specialist, and chair of ... Tennessee Health Science Center, analyzed the epidemiology and ... 1968 pandemics, as well as more recent 2009 ...
(Date:4/17/2014)... who treat patients with a severe and progressive ... agonizing treatment decision. , The drug sirolimus can ... shortness of breath. But some patients eventually may ... fatal complications following transplantation. , "It,s a terrible ... of Loyola University Medical Center,s LAM Clinic and ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3
... a radiology department and distributed through the medical director,s office, ... to significantly reduce the number of unnecessary cervical spine radiographs ... in the July issue of the Journal of the ... At the University of Rochester Medical Center in Rochester, NY, ...
... people worldwide do not have adequate access to surgical ... School of Public Health (HSPH). The researchers also found ... access to operating theatres (surgery sites) than those living ... settings often lack essential equipment. , A substantial ...
... When it comes to executing items on tomorrow,s to-do list, ... say psychologists at Washington University in St. Louis. People ... their intentions much better than people who try to execute ... that sleep enhances our ability to remember to do something ...
... By Jenifer Goodwin HealthDay Reporter , WEDNESDAY, ... disease patients who received fetal cell transplants in the ... can prevent the troublesome side effect. The findings ... said. "These findings lend much optimism to new ...
... There are 8.3 million children who are 5 years ... to formal education, can media intervention make a positive ... Sesame Workshop, which produces Kilimani Sesame, the Tanzanian version ... Hopkins Bloomberg School of Public Health in full collaboration ...
... ... , ... (PRWEB) June 30, 2010 -- Greenway Medical Technologies, Inc., provider of the integrated, single-database ... awarded a patent for its innovative template builder module used to create custom clinical ...
Cached Medicine News:Health News:Top down approach helps academic medical center reduce unnecessary emergency department X-rays 2Health News:More than 2 billion people worldwide lack access to surgical services 2Health News:Memory links to 40 winks 2Health News:Memory links to 40 winks 3Health News:Memory links to 40 winks 4Health News: Parkinson's Transplant Mystery Solved, Researchers Say 2Health News: Parkinson's Transplant Mystery Solved, Researchers Say 3Health News:Kilimani Sesame has positive impact on children in Tanzania: Johns Hopkins University study 2Health News:Greenway Awarded U.S. Patent For EHR Functionality and Workflow 2Health News:Greenway Awarded U.S. Patent For EHR Functionality and Workflow 3Health News:Greenway Awarded U.S. Patent For EHR Functionality and Workflow 4
All Keeler magnifiers and telescope are available on a clip to fit over the patient's own spectacle...
This set offers the full range of Keeler magnifiers and telescopes....
This set is designed to introduce the low vision practitioner to the Keeler telescopic system....
Significantly more compact and tidier in overall looks yet retain many of the excellent features of the more comprehensive Haag type systems., ,Filters include Cobalt blue; green (red free); neut...
Medicine Products: